Market entry for health and life sciences in Switzerland.
We need a Swiss presence without a Swiss office. Plan your Swiss entry.11Alto is a Zürich-based market-entry platform for international health companies. We represent, distribute and operate your products in Switzerland, so you can enter one of the world's most demanding health markets with confidence.
Read the market entry brief →Hard to enter. Worth it.
Switzerland is one of the world's most advanced health markets, and one of the hardest to enter. Its own regulations, four national languages and a fragmented healthcare landscape stop many good products at the border. 11Alto exists to open that border, responsibly.
Our mission: better access to proven health innovation for people in Switzerland, and a clear route in for the companies that build it.
Diagnostics Consumer health Parapharma Medtech
Expanding into digital health and emerging biotech.
What brands bring us.
Good products rarely fail in Switzerland. They stall: on a missing Swiss legal presence, on device registration, on a complex web of channels, from pharmacies and wholesalers to retailers, marketplaces and hospitals, and on a launch that has to work in several languages. 11Alto removes each of these roadblocks, so you can focus on your product.
Three ways in.
Represent
Your legal presence in Switzerland.
Distribute
Your products across Swiss healthcare.
Operate
Your brand, run in Switzerland.
- 01Assess
- 02Register
- 03Place
- 04Launch
- 05Scale
How we work.
One accountable partner. Specialist expertise where it's needed. Modern technology throughout.
- 1ContractOne agreement covers your entire Swiss entry.
- 1Accountable leadLegally responsible as your importer and Swiss authorised representative.
- 4Specialist disciplinesRegulatory affairs, logistics, channel and market access, communications.
- 0Layers of overheadModern technology and AI keep operations lean, fast and transparent.
That's how we keep market entry fast, compliant and lean.
A life-science nation.
A demanding health market.
| INDICATOR | VALUE |
|---|---|
| Health spending per person, 2024 | CHF 10,792 |
| Share paid out of pocket by households | 21.3% |
| Pharmacies nationwide | 1,830 |
| People who want prevention services at the pharmacy | ~60% |
| Average monthly health insurance premium, 2027 | CHF 412 |
Portfolio.
Newfoundland Diagnostics
A UK at-home health company helping people understand their health sooner, through self-tests, laboratory testing and supplements. 11Alto is their exclusive distributor in Switzerland, starting with self-tests.
Who you'll work with.
“A new generation of health brands is being built right now. I want Switzerland to be where they launch.”
David Martinez
FOUNDER & CEODavid has worked across the full journey of health products, from the factory floor to the market, at Roche, GE Healthcare and Rockwell Automation.
He began in engineering at GE Healthcare and Rockwell Automation, transferring production lines and working across quality, production supervision and production planning. He then spent a decade in Roche's Pharmaceuticals Division, across supply chain, manufacturing finance, commercial and strategic planning, and procurement.
He founded 11Alto in 2026 to bring that end-to-end view to health companies entering Switzerland.
Four languages. One market. One partner.
11 = ELF · ONZE · UNDICI · INDESCH · ELEVENBring us your Swiss launch.
Tell us your company, product category and timeline.
Schifflände 26, 8001 Zürich